{"title":"HPV E6/E7, O-GlcNAcylation and mitochondrial remodeling in cervical cancer: mechanistic links and translational opportunities.","authors":"Yingying Zhang, YiMei Tao, Huirong He, Ping Li, Minbin Chen","doi":"10.3389/fmolb.2026.1919738","DOIUrl":"https://doi.org/10.3389/fmolb.2026.1919738","url":null,"abstract":"<p><p>Persistent high-risk human papillomavirus (HPV) infection initiates cervical carcinogenesis, while progression and treatment resistance also involve metabolic adaptation. O-GlcNAcylation is a reversible post-translational modification (PTM) controlled by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), with UDP-GlcNAc generated by the hexosamine biosynthetic pathway (HBP) serving as the donor substrate. This review evaluates evidence linking HPV E6/E7-associated metabolic demand, HBP flux, O-GlcNAcylation, and mitochondrial function. We distinguish observations made under untreated conditions from acute treatment responses, identify whether validated resistant models were used, and examine HPV genotype as a source of heterogeneity. Cervical cancer studies support links between O-GlcNAcylation and pathways involved in growth and survival, but no mitochondrial O-GlcNAcylation site has been causally validated in HPV-positive cervical cancer. We therefore grade evidence by model, temporal context, and causal depth and place the proposed relationships within a broader PTM network. This synthesis separates findings obtained in cervical cancer from mechanisms inferred from other systems and identifies the main gaps limiting biomarker and therapeutic development.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1919738"},"PeriodicalIF":4.4,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760441/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ryan C Meng, Alexandra Lesko, Fred Robinson, Elizabeth Baraban, Kai H Darke, Brian D Piening, Evan J Fertig
{"title":"Exploratory analysis of cell-free miRNA expression changes in patients with isolated first seizure and new-onset epilepsy.","authors":"Ryan C Meng, Alexandra Lesko, Fred Robinson, Elizabeth Baraban, Kai H Darke, Brian D Piening, Evan J Fertig","doi":"10.3389/fmolb.2026.1788160","DOIUrl":"https://doi.org/10.3389/fmolb.2026.1788160","url":null,"abstract":"<p><p>One in ten individuals will experience a seizure in their lives, but only 43%-61% will be diagnosed with new-onset epilepsy (NOE). Existing methods to distinguish between a first unprovoked seizure and a diagnosis of epilepsy are inadequate and often lead to unnecessary treatment with antiseizure medications. To uncover potential targets associated with NOE, we analyzed cell-free circulating miRNA expression in plasma samples obtained from 20 patients who presented with a first unprovoked seizure. Patients were monitored for 2 years following their initial seizure, and a total of 7 patients experienced a second seizure within the follow-up period. Analysis of the miRNA expression levels revealed 15 differentially expressed miRNAs between patients who experienced only a first unprovoked seizure versus those who had a second seizure. These 15 miRNAs were experimentally linked as regulators to 160 genes related to epilepsy, including genes involved in the mTOR and WNT signaling pathways. These findings highlight a number of key circulating miRNA targets that may be further developed as a biomarker signature in larger cohorts and may offer insights into factors associated with epileptogenesis.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1788160"},"PeriodicalIF":4.4,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Compartment-specific m<sup>7</sup>G RNA modification in cancer: mechanisms, tumor adaptation, and therapeutic vulnerabilities.","authors":"Xiaoxiao Tian, Di Huang, Chaonan Guan","doi":"10.3389/fmolb.2026.1951991","DOIUrl":"https://doi.org/10.3389/fmolb.2026.1951991","url":null,"abstract":"<p><p>N7-methylguanosine (m<sup>7</sup>G) is distributed across several RNA classes and regulates distinct stages of gene expression. The best-characterized form is the 5'cap of messenger RNA, although m<sup>7</sup>G also occurs in transfer RNA, ribosomal RNA, internal messenger RNA, circular RNA, and transfer RNA-derived small RNAs. Cancer-associated m<sup>7</sup>G dysregulation therefore cannot be ascribed to a single enzyme or molecular outcome. The strongest causal evidence concerns the METTL1-WDR4 complex, which modifies transfer RNA and reshapes codon-biased translation, promoting proliferation, metastasis, metabolic adaptation, stress tolerance, and treatment resistance. Studies of internal messenger RNA m<sup>7</sup>G report reader-dependent effects on stability, decay, translation, and stress-granule partitioning. Cap biochemistry is established, whereas catalytic cancer mechanisms involving ribosomal RNA remain less resolved. In preclinical models, these pathways connect tumor-cell adaptation with stromal communication, immune evasion, and treatment response. The biological effects of m<sup>7</sup>G vary with the modified RNA and the proteins favored by translation; tumor-restrictive activity emerges when altered tRNA modification increases the production of cell-cycle inhibitory proteins. This review organizes established and emerging mechanisms by RNA compartment and examines the substrate-dependent balance between tumor promotion, tumor restriction, and treatment sensitivity. It also evaluates biomarker strategies, emerging pharmacological and RNA-directed interventions, and the methodological standards needed to distinguish direct m<sup>7</sup>G-dependent effects from regulator expression correlations. A site-resolved, substrate-specific understanding of m<sup>7</sup>G may reveal translational dependencies that are actionable without disrupting essential RNA metabolism in normal tissues.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1951991"},"PeriodicalIF":4.4,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13755690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elena A Cherkasova, Thomas Hill, Stefan Barisic, Long Chen, Jamie Diemer, Neelam Redekar, Richard W Childs
{"title":"Long-read RNA sequencing reveals full-length HERV transcripts and novel ERVE-4 isoforms with potential immunotherapeutic relevance in clear cell renal cell carcinoma.","authors":"Elena A Cherkasova, Thomas Hill, Stefan Barisic, Long Chen, Jamie Diemer, Neelam Redekar, Richard W Childs","doi":"10.3389/fmolb.2026.1941192","DOIUrl":"https://doi.org/10.3389/fmolb.2026.1941192","url":null,"abstract":"<p><strong>Introduction: </strong>Human endogenous retroviruses (HERVs) are increasingly recognized as sources of tumor-associated antigens and potential targets for cellular immunotherapy. However, their repetitive sequences and noncanonical splicing patterns complicate accurate transcript annotation using common short-read RNA sequencing. This study aimed to improve HERV transcriptome annotation using long-read RNA sequencing.</p><p><strong>Methods: </strong>We developed a bioinformatics workflow for comprehensive annotation of HERV expression using long-read RNA sequencing, with validation using short-read RNA sequencing. We applied this workflow to ERVE-4, a HERV element previously shown to be selectively expressed in clear cell renal cell carcinoma (ccRCC) and to encode immunogenic peptides currently under clinical investigation as targets for cellular immunotherapy.</p><p><strong>Results: </strong>Long-read sequencing captured full-length HERV transcripts, improved mapping across repetitive regions, and enabled reconstruction of HERV isoforms. The workflow identified hundreds of HERV loci in long-read datasets absent from corresponding short-read annotations. Analysis of ERVE-4 revealed previously uncharacterized isoforms, whose expression was validated across multiple ccRCC tumors using RT-dPCR.</p><p><strong>Discussion: </strong>Long-read RNA sequencing improves the resolution and completeness of HERV transcriptome annotation. Novel ERVE-4 isoforms substantially expand the known antigenic coding potential of ERVE-4 possibly implying discovery of novel peptide targets for immunotherapy in ccRCC.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1941192"},"PeriodicalIF":4.4,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13754704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hao Di Liang, Shui Bo Xu, Yi Ting Zhou, Li Ling Zheng, Chien Yi Koay, Hooi Yeen Yap, Bee Leng Lua
{"title":"IRS-1 phase separation bridges IGF-1R signaling and the MITF/TYR axis to control melanogenesis.","authors":"Hao Di Liang, Shui Bo Xu, Yi Ting Zhou, Li Ling Zheng, Chien Yi Koay, Hooi Yeen Yap, Bee Leng Lua","doi":"10.3389/fmolb.2026.1947504","DOIUrl":"https://doi.org/10.3389/fmolb.2026.1947504","url":null,"abstract":"<p><p>Melanogenesis is well known to be activated by the α-MSH/MITF signaling pathway. Recent studies have further revealed that the IGF-1/IGF-1R metabolic signaling axis can also induce melanin synthesis. Here, we demonstrate that IRS-1, a key downstream adaptor of both IGF-1R and the insulin receptor (IR), acts as a bridge by connecting the upstream IGF-1R signaling with the downstream MITF/TYR axis to promote melanogenesis. Importantly, this function of IRS-1 may be tissue-specific, as insulin alone fails to stimulate melanogenesis. Deletion of the self-interaction region (SAR) abolishes the phase separation of IRS-1, thereby preventing the activation of melanogenesis. Taken together, our findings reveal a novel function of IRS-1 phase separation in melanogenesis. This work not only sheds light on understanding the regulatory mechanism of melanin homeostasis but also provides a potential strategy for cosmetics companies to develop more effective whitening products.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1947504"},"PeriodicalIF":4.4,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13756206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation.","authors":"Xinhua Xu, Xiaochen Ren, Zeng Yuan","doi":"10.3389/fmolb.2026.1988095","DOIUrl":"10.3389/fmolb.2026.1988095","url":null,"abstract":"<p><p>High-grade serous ovarian carcinoma (HGSOC) is marked by extensive genomic instability, characterized by near-universal <i>TP53</i> mutations, frequent homologous recombination deficiency (HRD), widespread copy-number alterations, and complex structural rearrangements. However, much of our current understanding of this molecular landscape has been derived from exome sequencing, microarrays, and short-read whole-genome sequencing, which are limited in their ability to resolve repetitive and structurally complex genomic regions. Long-read sequencing, together with telomere-to-telomere reference assemblies, is beginning to reveal previously inaccessible aspects of HGSOC genome architecture. Exploratory studies have reported centromeric and transposable-element hypomethylation, chromosome-arm-specific telomere shortening, and complex extrachromosomal DNA (ecDNA) architectures associated with enhancer regulation and transposable-element activity. Complementary studies have also identified ongoing LINE-1 retrotransposition in HGSOC. Together, these observations suggest that repetitive DNA, epigenetic instability, and complex genome architecture may contribute to HGSOC heterogeneity and tumor evolution, although their causal relationships remain uncertain. Nevertheless, genome-wide long-read evidence in HGSOC currently derives primarily from two small studies involving six and 12 patients, respectively, underscoring the need for validation in larger, independent cohorts.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1988095"},"PeriodicalIF":4.4,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13752971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Elucidation of the mechanism of human growth hormone-Fc fusion protein in accelerating tibial fracture healing in rats via untargeted metabolomics.","authors":"Jianyang Gu, Juntong Liu, Binghuai Peng, Baisong Zhou, Zhuonan Li, Hao Zhang, Tianyu Zhang, Haoming Jiang, Ruixin Sun, Ping Gong, Han Liu","doi":"10.3389/fmolb.2026.1971992","DOIUrl":"10.3389/fmolb.2026.1971992","url":null,"abstract":"<p><strong>Background: </strong>Fracture healing has always been a major challenge in clinical practice. This study aims to explore the effect of human growth hormone-Fc fusion protein on the healing of a rat tibial fracture model and its possible mechanisms of action.</p><p><strong>Methods: </strong>By assessing the levels of growth hormone effectors IGF-1 and IGFBP-3 in rats, combined with Micro-CT scanning and pathological staining slices, we investigated the pathological effects of subcutaneous injection of human growth hormone-Fc fusion protein for 28 days on the healing of rat tibial fractures. Serum metabolomics studies were conducted using the AB Triple TOF 6600 mass spectrometer to further investigate the bio-metabolites relevant to fracture healing influenced by the human growth hormone-Fc fusion protein.</p><p><strong>Results: </strong>The study showed that after administration of the growth hormone-Fc fusion protein, IGF-1 and IGFBP-3 levels in rat blood were significantly increased. Micro-CT scans and pathological staining also demonstrated that the high-dose group had a marked promoting effect on fracture healing, with a healing rate significantly superior to the positive drug group; the medium and low dose groups also showed certain degrees of promotion. Metabolomic results revealed that the growth hormone could regulate 17 metabolites, affecting 8 metabolic pathways in relation to fracture healing.</p><p><strong>Conclusion: </strong>The study found that the growth hormone-Fc fusion protein shortened the healing period of the rat tibial fracture model by more than 1 week, possibly by influencing the levels of IGF-1 and IGFBP-3 factors, as well as regulating 17 metabolites in 8 metabolic pathways-including starch and sucrose metabolism, galactose metabolism, glycerophospholipid metabolism, terpene backbone biosynthesis, glyoxylate and dicarboxylate metabolism, retinol metabolism, glycine, serine, and threonine metabolism, and inositol phosphate metabolism-thus promoting fracture healing. This provides a basis for subsequent larger-scale, multicenter experiments and clinical translational research on FcGH in the treatment of fractures.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1971992"},"PeriodicalIF":4.4,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiyang Guo, Junling Liu, Long Xu, Tingyi Yan, Zhendong Zheng
{"title":"Identification and characterization of a novel fungal pyranose 2-oxidase from the <i>Punctularia strigosozonata</i> with potent cytotoxicity against pancreatic carcinoma cell lines.","authors":"Jiyang Guo, Junling Liu, Long Xu, Tingyi Yan, Zhendong Zheng","doi":"10.3389/fmolb.2026.1914323","DOIUrl":"10.3389/fmolb.2026.1914323","url":null,"abstract":"<p><p>Pyranose oxidase (POx) is a FAD-dependent oxidoreductase that catalyzes the oxidation of D-glucose to 2-keto-D-glucose with concomitant production of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Although POx has been well characterized in several fungi and bacteria, its potential in cancer therapy remains largely unexplored. In this study, we identified a novel pyranose 2-oxidase, designated PsPOx, from the wood-decaying fungus <i>Punctularia strigosozonata</i> through gene mining. The gene was codon-optimized, synthesized, and heterologously expressed in <i>Escherichia coli</i>. The recombinant enzyme was purified and biochemically characterized. Sequence alignment and structural modeling confirmed that PsPOx possesses all conserved features of the GMC superfamily. Kinetic analysis showed that PsPOx exhibits the highest catalytic efficiency (<i>k</i> <sub>cat</sub>/<i>K</i> <sub>m</sub> = 85.09 mM<sup>-1</sup> s<sup>-1</sup>) towards D-glucose, with a <i>K</i> <sub>m</sub> value of 0.8375 mM, indicating a strong substrate affinity. Using the CCK-8 assay, PsPOx demonstrated potent dose-dependent cytotoxicity against three human pancreatic carcinoma cell lines (PANC-1, AsPC-1, and BxPC-3), with IC50 values of 257.8, 195.2, and 176.2 ng mL<sup>-1</sup>, respectively. However, the IC<sub>50</sub> value for the normal human pancreatic epithelial cell line hTERT-HPNE was 195.6 ng mL<sup>-1</sup>, which was comparable to those for AsPC-1 and BxPC-3, indicating that free PsPOx lacks selectivity between tumor and normal cells. Mechanistic studies revealed that PsPOx treatment increased intracellular and mitochondrial reactive oxygen species (ROS) levels, induced G0/G1 cell cycle arrest, downregulated Cyclin D1 and PCNA expression, and triggered apoptosis in BxPC-3 cells. These results preliminarily demonstrate that PsPOx possesses antitumor activity <i>in vitro</i> and may serve as a candidate for further development.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1914323"},"PeriodicalIF":4.4,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13752094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Franziska Koch, Dirk Albrecht, Solvig Görs, Carolin B M Müller-Kiedrowski, Klaus Wimmers, Björn Kuhla
{"title":"Renal clearance rate, estimated renal reabsorption ratio, and kidney proteome of Holstein dairy cows with divergent milk urea concentrations.","authors":"Franziska Koch, Dirk Albrecht, Solvig Görs, Carolin B M Müller-Kiedrowski, Klaus Wimmers, Björn Kuhla","doi":"10.3389/fmolb.2026.1819426","DOIUrl":"10.3389/fmolb.2026.1819426","url":null,"abstract":"<p><p>Recent mRNA expression studies have proposed various renal proteins to be involved in the excretion of electrolytes, amino acids, and charged compounds to reduce urea, uric acid, and the creatinine clearance rates of dairy cows with high milk urea (HMU) concentrations. Hence, the aim of this study is to analyze the renal clearance of monovalent ions, amino acids and lactate, and the kidney proteome of dairy cows with high and low milk urea concentrations. HMU cows had higher plasma carnosine concentrations but lower renal carnosine clearance and transporter expression. HMU cows possessed increased plasma citrulline but reduced arginase abundance, suggesting downregulated urea detoxification. Pathway analysis revealed proteasomal activation to increase the degradation of proteins which could clog the filter barrier in HMU cows. However, reduced urea, uric acid, and the creatinine clearance rates of HMU cows could not be explained by reduced expression of their transporters but by altered local solute, such as carnosine handling and a lighter relative kidney weight.</p>","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"1819426"},"PeriodicalIF":4.4,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13747852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Editorial: Exploring AI's role in disease prediction and diagnosis through medical big data.","authors":"Yulin Zhang","doi":"10.3389/fmolb.2026.2005303","DOIUrl":"https://doi.org/10.3389/fmolb.2026.2005303","url":null,"abstract":"","PeriodicalId":12465,"journal":{"name":"Frontiers in Molecular Biosciences","volume":"13 ","pages":"2005303"},"PeriodicalIF":4.4,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}